Table 1.

Evaluation of EGCG and EGCG${}_{ox}$’s effects on the insulin aggregation process.

Assessed by Change in ${\mathit{t}}_{50}$
Protein	Conditions	EGCG	EGCG ${}_{\mathbf{ox}}$
Insulin	PB-Q	Inhibitory 1	Inhibitory
	PB-A	No Effect	Inhibitory
	AC-Q	No Effect	Inhibitory
	AC-A	No Effect	Inhibitory
$\alpha$-synuclein	pH 7	Inhibitory	Inhibitory
	pH 6	No Effect	Inhibitory
Assessed by Change in ${\mathit{I}}_{\mathit{max}}$
Protein	Conditions	EGCG	EGCG ${}_{\mathbf{ox}}$
Insulin	PB-Q	Inhibitory	Inhibitory
	PB-A	No Effect	Inhibitory
	AC-Q	No Effect	Enhancing
	AC-A	No Effect	Enhancing
$\alpha$-synuclein	pH 7	Inhibitory	Inhibitory
	pH 6	Inhibitory	Inhibitory

${}^1$ Established by comparing experimental values of $t_{50}$ or $I_{max}$ of control samples with the ones determined in the presence of EGCG or EGCG${}_{ox}$ using one-way ANOVA (See Figure S7). p < 0.01 was accepted as statistically significant.